TW250482B - - Google Patents

Info

Publication number
TW250482B
TW250482B TW081109861A TW81109861A TW250482B TW 250482 B TW250482 B TW 250482B TW 081109861 A TW081109861 A TW 081109861A TW 81109861 A TW81109861 A TW 81109861A TW 250482 B TW250482 B TW 250482B
Authority
TW
Taiwan
Application number
TW081109861A
Inventor
P Rossignol Daniel
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of TW250482B publication Critical patent/TW250482B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW081109861A 1991-10-11 1992-12-09 TW250482B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77610091A 1991-10-11 1991-10-11
US07/935,050 US5530113A (en) 1991-10-11 1992-08-25 Anti-endotoxin compounds

Publications (1)

Publication Number Publication Date
TW250482B true TW250482B (zh) 1995-07-01

Family

ID=25106455

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081109861A TW250482B (zh) 1991-10-11 1992-12-09

Country Status (4)

Country Link
US (1) US5530113A (zh)
KR (1) KR930007942A (zh)
TW (1) TW250482B (zh)
ZA (1) ZA927751B (zh)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648343A (en) * 1994-02-28 1997-07-15 The University Of Georgia Research Foundation Method for treating LPS-mediated disorders
US6417172B1 (en) * 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5681824A (en) 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
US5952309A (en) * 1995-09-29 1999-09-14 Eisai Company, Ltd. Method for treating alcoholic liver disease
DE69733651T2 (de) * 1996-07-03 2006-05-18 Eisai Co., Ltd. Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung
US6444654B1 (en) 1997-01-21 2002-09-03 Board Of Regents Of University Of Nebraska Isolated asgal lipopolysaccharides and use of same to inhibit innate immune response
US6172220B1 (en) 1997-01-21 2001-01-09 Board Of Regents Of University Of Nebraska Isolated algal lipopolysaccharides and use of same to inhibit endotoxin-initiated sepsis
US6713654B1 (en) 1997-08-29 2004-03-30 The Johns Hopkins University School Of Medicine Antimicrobial compounds
AU2003200765B2 (en) * 1997-08-29 2007-01-25 The Johns Hopkins University Antimicrobial compounds
DE69822167T2 (de) * 1997-08-29 2005-02-17 The Johns Hopkins University Antimikrobielle verbindungen
US6011066A (en) * 1998-02-02 2000-01-04 Veterans General Hospital-Taipei Method for treating septic shock
CA2359478A1 (en) 1999-01-14 2000-07-20 Daniel P. Rossignol Administration of an anti-endotoxin drug by intravenous infusion
US20040006242A1 (en) 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
AU2008202882B2 (en) * 1999-02-01 2011-06-16 Eisai R & D Management Co., Ltd. Immunological adjuvant compound
IL151314A0 (en) * 2000-02-18 2003-04-10 Eisai Co Ltd Micelles, methods for their preparation and methods for delivery of micelles to patients
US20040198652A1 (en) * 2001-04-24 2004-10-07 Carter J. Paul Methods and compositions for preventing and treating septic shock and endotoxemia
US20040254128A1 (en) 2001-08-10 2004-12-16 Seiichi Kobayashi Treatment and prevention of heat shock protein-associated diseases and conditions
TW200403250A (en) * 2002-06-18 2004-03-01 Sankyo Co Glucoxyl lipid A1-carboxymethyl compounds
MXPA05007295A (es) 2003-01-06 2005-09-30 Corixa Corp Ciertos compuestos de fosfato de aminoalquil glucosaminida y su uso.
US7960522B2 (en) 2003-01-06 2011-06-14 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
EP2007199A2 (en) * 2006-02-09 2008-12-31 Elevance Renewable Sciences, Inc. Antimicrobial compositions, methods and systems
WO2007092632A2 (en) * 2006-02-09 2007-08-16 Elevance Renawable Sciences, Inc. Surface coating compositions and methods
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
PL2486938T3 (pl) 2006-09-26 2018-08-31 Infectious Disease Research Institute Kompozycja szczepionki zawierająca syntetyczny adiuwant
CA2698668A1 (en) * 2007-09-07 2009-03-19 University Of Georgia Research Foundation, Inc. Synthetic lipid a derivative
ES2606563T3 (es) 2009-06-05 2017-03-24 Infectious Disease Research Institute Adyuvantes lipídicos de glucopiranosilo sintéticos y composiciones de vacuna que contienen los mismos
CN102917715B (zh) 2010-02-16 2015-07-01 Tfk株式会社 疾病的预防改善剂、持久力提高剂、抗疲劳剂、以及使用它们的药品和饮食品
EP2694099B1 (en) 2011-04-08 2019-10-16 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
PL2850431T3 (pl) 2012-05-16 2018-09-28 Immune Design Corp. Szczepionki przeciwko HSV-2
SG11201508092YA (en) 2013-04-18 2015-10-29 Immune Design Corp Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
US11458151B2 (en) 2018-02-12 2022-10-04 Inimmune Corporation Toll-like receptor ligands
AU2019400340A1 (en) 2018-12-17 2021-05-20 Eisai R&D Management Co., Ltd. Formulation comprising liposomes

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495346A (en) * 1981-03-30 1985-01-22 Wisconsin Alumni Research Foundation Method of preparing a disaccharide
US5057598A (en) * 1983-05-06 1991-10-15 Centocor, Inc. Monoclonal antibodies reactive with endotoxin core
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4629722A (en) * 1984-07-12 1986-12-16 Ribi Immunochem Research, Inc. Method of inhibiting the onset of acute radiation syndrome
US5066794A (en) * 1984-08-24 1991-11-19 Daiichi Pharmaceutical Co., Ltd. Process for preparing a disaccharide derivative
JPS6153295A (ja) * 1984-08-24 1986-03-17 Dai Ichi Seiyaku Co Ltd ジサツカライド誘導体
NL8601551A (nl) * 1985-06-28 1987-01-16 Sandoz Ag Nieuwe saccharides, hun bereiding en farmaceutische samenstellingen, die hen bevatten.
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
JP2535048B2 (ja) * 1988-02-29 1996-09-18 第一製薬株式会社 新規ジサッカライド誘導体及びその塩
US5134230A (en) * 1988-03-02 1992-07-28 Daiichi Pharmaceutical Co., Ltd. 2-Deoxy-2-aminoglucopyranoside derivatives
ZA881430B (zh) * 1988-03-02 1988-10-28
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5041427A (en) * 1989-07-21 1991-08-20 Wisconsin Alumni Research Foundation Lipid A derivatives
US5158939A (en) * 1989-07-21 1992-10-27 Wisconsin Alumni Research Foundation Method of stimulating the immune systems of animals and compositions useful therefor
JPH0655749B2 (ja) * 1989-09-20 1994-07-27 日本たばこ産業株式会社 リピッドａ単糖類縁体
JP2839916B2 (ja) * 1989-10-20 1998-12-24 三共株式会社 リピドａ３位エーテル類縁体
US5158941A (en) * 1990-06-08 1992-10-27 E. I. Du Pont De Nemours And Company Lipid A analog as stimulant for production of interleukin-1 in human monocytes and tumor cell growth inhibitor
AU660325B2 (en) * 1991-10-11 1995-06-22 Eisai Co. Ltd. Anti-endotoxin compounds and related molecules and methods

Also Published As

Publication number Publication date
KR930007942A (ko) 1993-05-20
ZA927751B (en) 1993-06-10
US5530113A (en) 1996-06-25

Similar Documents

Publication Publication Date Title
DE9101110U1 (zh)
TW250482B (zh)
DE4290032T1 (zh)
DE4291983T1 (zh)
DE9101673U1 (zh)
DE9100911U1 (zh)
DE9101419U1 (zh)
DE9102196U1 (zh)
DE9103971U1 (zh)
DE9101162U1 (zh)
DE9101352U1 (zh)
DE9101880U1 (zh)
DE9103326U1 (zh)
DE9102204U1 (zh)
DE9101497U1 (zh)
DE9101746U1 (zh)
DE9102086U1 (zh)
DE9103736U1 (zh)
DE9102450U1 (zh)
DE9101047U1 (zh)
DE9100832U1 (zh)
DE9103336U1 (zh)
DE9103623U1 (zh)
DE9101806U1 (zh)
DE9101079U1 (zh)